SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant...............................................[X]
Filed by a Party other than the Registrant............................[ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
[ ] Definitive Proxy Statement
[X] Definitive Additional Materials
[ ] Soliciting Material Pursuant to ss. 240.14a-11(c) or ss. 240.14a-12
OrthoLogic Corp.
----------------------------------------------------------------------
(Name of Registrant As Specified In Its Charter)
----------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[ ] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), 14a-6(i)(2) or Item
22(a)(2) of Schedule 14A.
[ ] $500 per each party to the controversy pursuant to Exchange Act Rule
14a-6(i)(3).
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1) Title of each class of securities to which transaction applies:
2) Aggregate number of securities to which transaction applies:
3) Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11 (Set forth the
amount on which the filing fee is calculated and state how it
was determined):
4) Proposed maximum aggregate value of transaction:
5) Total fee paid:
[X] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.
1) Amount Previously Paid:
---------------------------------------
2) Form, Schedule or Registration Statement No.:
-----------------
3) Filing Party:
-------------------------------------------------
4) Date Filed:
---------------------------------------------------
<PAGE>
May 7, 1996
Ms. Jill Lyons
Director, Proxy Advisory Services
Institutional Shareholder Services
7200 Wisconsin Avenue, Suite 1001
Bethesda, MD 20814
RE: OrthoLogic Corp./1987 Stock Option Plan
Dear Ms. Lyons:
This letter confirms that OrthoLogic's Board of Directors intends to adopt a
resolution prohibiting the repricing of outstanding stock options. Furthermore,
the resolution disallows the surrender of outstanding options in conjunction
with a grant of new options in substitution therefor at an exercise price lower
than the price of the options surrendered.
Should you have any questions concerning this matter, please do not hesitate to
contact me at 602.437.5520.
Sincerely,
Allen R. Dunaway
Vice President, Chief Financial Officer
